Immunogen Inc (DELISTED) (IMGN:DL)
31.25
USD |
NASDAQ |
Feb 09, 16:00
Immunogen Max Drawdown (5Y)
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| January 31, 2024 | 90.72% |
| December 31, 2023 | 90.72% |
| November 30, 2023 | 90.72% |
| October 31, 2023 | 90.72% |
| September 30, 2023 | 90.72% |
| August 31, 2023 | 90.72% |
| July 31, 2023 | 90.72% |
| June 30, 2023 | 90.72% |
| May 31, 2023 | 90.72% |
| April 30, 2023 | 90.72% |
| March 31, 2023 | 90.72% |
| February 28, 2023 | 90.72% |
| January 31, 2023 | 90.72% |
| December 31, 2022 | 90.72% |
| November 30, 2022 | 90.72% |
| October 31, 2022 | 90.72% |
| September 30, 2022 | 90.72% |
| August 31, 2022 | 90.72% |
| July 31, 2022 | 90.72% |
| June 30, 2022 | 90.72% |
| May 31, 2022 | 90.72% |
| April 30, 2022 | 90.72% |
| March 31, 2022 | 90.72% |
| February 28, 2022 | 90.72% |
| January 31, 2022 | 90.72% |
| Date | Value |
|---|---|
| December 31, 2021 | 90.72% |
| November 30, 2021 | 90.72% |
| October 31, 2021 | 90.72% |
| September 30, 2021 | 92.07% |
| August 31, 2021 | 92.07% |
| July 31, 2021 | 92.07% |
| June 30, 2021 | 92.07% |
| May 31, 2021 | 92.07% |
| April 30, 2021 | 92.07% |
| March 31, 2021 | 92.07% |
| February 28, 2021 | 92.07% |
| January 31, 2021 | 92.07% |
| December 31, 2020 | 92.07% |
| November 30, 2020 | 92.07% |
| October 31, 2020 | 92.07% |
| September 30, 2020 | 92.07% |
| August 31, 2020 | 92.07% |
| July 31, 2020 | 92.07% |
| June 30, 2020 | 92.07% |
| May 31, 2020 | 92.07% |
| April 30, 2020 | 92.07% |
| March 31, 2020 | 92.07% |
| February 29, 2020 | 92.07% |
| January 31, 2020 | 92.07% |
| December 31, 2019 | 92.07% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| AbbVie, Inc. | 21.89% |
| Pfizer Inc. | 58.95% |
| Johnson & Johnson | 18.44% |
| Merck & Co., Inc. | 43.45% |
| Cerevel Therapeutics Holdings Inc (DELISTED) | -- |